Rapid and Extensive Expansion in the United States of a New Multidrug-resistant Escherichia coli Clonal Group, Sequence Type 1193.
Clin Infect Dis
; 68(2): 334-337, 2019 01 07.
Article
en En
| MEDLINE
| ID: mdl-29961843
ABSTRACT
We describe the rapid and ongoing emergence across multiple US cities of a new multidrug-resistant Escherichia coli clone-sequence type (ST) 1193-resistant to fluoroquinolones (100%), trimethoprim-sulfamethoxazole (55%), and tetracycline (53%). ST1193 is associated with younger adults (age <40 years) and currently comprises a quarter of fluoroquinolone-resistant clinical E. coli urine isolates.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Enfermedades Transmisibles Emergentes
/
Farmacorresistencia Bacteriana Múltiple
/
Escherichia coli
/
Infecciones por Escherichia coli
Tipo de estudio:
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
/
Screening_studies
Límite:
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Clin Infect Dis
Asunto de la revista:
DOENCAS TRANSMISSIVEIS
Año:
2019
Tipo del documento:
Article